Home > Healthcare > Medical Devices > Diagnostic Devices > Coagulation Analyzers Market

Coagulation Analyzers Market Trends

Report ID: GMI12812
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Coagulation Analyzers Market Trends

The market is witnessing several transformative trends. One key trend is the integration of artificial intelligence (AI) and machine learning in analyzers, which enhances diagnostic accuracy and operational efficiency. AI-powered devices can predict abnormalities, streamline workflows, and enable real-time data sharing with electronic medical records (EMRs).

Another significant trend is the rising demand for point-of-care testing (POCT) solutions. These portable analyzers offer quick results, reducing the need for centralized laboratory infrastructure and enabling faster clinical decisions.
The growing focus on personalized medicine is shaping the market as well. Coagulation analyzers now support tailored treatment plans by providing precise and patient-specific data. Furthermore, the adoption of cloud-based data management systems allows remote monitoring and analysis, improving accessibility in remote and underserved areas. The increasing emphasis on automation and the development of compact, user-friendly devices are also major trends driving adoption.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global coagulation analyzers industry was valued at USD 4.6 billion in 2024 and is projected to grow at a 6.1% CAGR from 2025 to 2034, driven by the rising prevalence of blood disorders such as hemophilia and thrombosis.

The consumables segment is expected to grow at a CAGR of 6.3%, reaching over USD 5.5 billion by 2034, supported by the recurring demand for reagents and calibrators in laboratories and diagnostic centers.

The U.S. coagulation analyzers market was valued at USD 1.5 billion in 2024 and is anticipated to grow at a CAGR of 5.3% from 2025 to 2034, driven by significant healthcare expenditure and advanced diagnostic capabilities.

Key players in the market include Abbott, DiaSys, Erba Mannheim, HELENA LABORATORIES, HemoSonics, HORIBA, iLine, mindray, RANDOX, Roche, SEKISUI, SIEMENS Healthineers, and Stago.